Not applicableApproved For MarketingNCT00989807
What this trial is testing
Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Gilead Sciences